NCT07083089 - Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR) | Biotech Hunter

Enrollment

309

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Mild Cognitive Impairment (MCI) AmnesticParkinson Disease (PD)Healthy Participants

Interventions

OTHER

Thorough Hearing assessment

Otoscopy Tympanometry Tonal audiometry (air and bone conduction) Vocal audiometry (in silence and in noise) Distorsion Products of OtoAcoustic Emissions (DPOAE) Middle Ear Muscle Reflex (MEMR) Auditory Brainstem Response (ABR) Electrocochleography (EcochG)

Trial Locations (4)

30900

RECRUITING

CHU Carémeau, Nîmes

34080

RECRUITING

CHU Gui de Chauliac, Montpellier

69100

ACTIVE_NOT_RECRUITING

Hospices Civils de Lyon, Hôpital des Charpennes, Villeurbanne

06000

ACTIVE_NOT_RECRUITING

CHU Nice, Nice